Top 5 undervalued ASX 200 stocks

One of the best ways to create wealth in the stock market is by buying exceptionally high-quality companies when they are trading at a meaningful discount to their intrinsic value.
The following are the top 5 ASX 200 undervalued stocks that fit this description and offer high potential for future growth.

Top 5 undervalued ASX 200 stocks

Pro Medicus Limited (ASX: PME)

WiseTech Global Limited (ASX: WTC) 

TechnologyOne Limited (ASX: TNE) 

CSL Limited (ASX: CSL) 

Xero Limited (ASX: XRO) 

Pro Medicus Limited (ASX: PME)

is one of the top undervalued ASX 200 stocks because the share price has fallen 34% in the last 12 months even though business performance has remained strong.

The company in HY26 reported strong financial results where revenue increased 28.4% year-on-year to $124.8 million while underlying EBIT rose 29.7% to $90.7 million.

Forward contracted revenue stands above $1 billion across five years which supports visibility while higher adoption of its transaction-based model helps create predictable annuity-style income.

A recent 5-year contract renewal worth $37 million with Northwestern Medicine on 13 April 2026 at higher pricing and minimum volumes also highlights strong client retention and pricing power.

WiseTech Global Limited (ASX: WTC) 

has become one of the more attractive undervalued ASX 200 stocks as the share price has fallen 55% over the past 12 months even though operations remained strong.
The company in 1H26 reported total revenue of $672.0 million which increased 76% year-on-year because of CargoWise expansion and the e2open acquisition.

Underlying NPAT rose by 2% to $114.5 million while EBITDA increased 31% to $252.1 million but margins declined due to acquisition costs and integration impacts when compared to the previous corresponding period.

Management has reaffirmed FY26 guidance with expected revenue of $1.39–$1.44 billion which suggests improving margins and supports long-term global growth as the company builds a dominant logistics software ecosystem.

TechnologyOne Limited (ASX: TNE) 

is a solid pick among current undervalued ASX 200 stocks while the company in FY25 reported record financials with profit before tax up 19% to $181.5 million and total ARR up 18% to $554.6 million which shows strong growth compared to the prior corresponding period.

The model remains dominated by recurring revenue as SaaS and recurring revenue rose 19% while net revenue retention stood at 115% which shows strong customer stickiness and expansion within its existing base.

Cash flow also remains strong as free cash flow increased 55% while margins improved and the balance sheet is debt free.

Management has upgraded FY26 guidance to 18–20% profit growth and 16–18% ARR growth which supports confidence in its pipeline and strengthens the long-term outlook driven by AI innovation and global expansion.

CSL Limited (ASX: CSL) 

is also a solid pick among undervalued ASX 200 stocks and its share price has fallen 41.27% over the last 12 months which may offer an attractive entry point because of solid fundamentals.
The company in 1H26 reported revenue of $8.3 billion which is 4% lower than the prior corresponding period while NPATA fell 7% to $1.9 billion mainly due to policy changes and one-off restructuring impacts.

Recent updates show expanded share buybacks up to US$750 million along with transformation driven cost savings and new product launches such as HEMGENIX and ANDEMBRY which will support long-term growth.

CSL has kept its FY26 guidance unchanged with expected revenue growth of 2–3% and NPATA growth of 4–7% which is supported by stronger momentum in the second half and helps position the company for recovery and steady growth.

Xero Limited (ASX: XRO) 

is among the best undervalued ASX 200 stocks and its share price has fallen 54.63% over the last 12 months due to broad sector wide selloff even though the business has shown strong core growth.
The company in H1 FY26 reported operating revenue of $1.19 billion which is 20% higher year-on-year and it also recorded adjusted EBITDA of $351 million.

Subscriber numbers reached 4.59 million which reflects steady growth and ARPU rose to $49.63 which shows effective monetisation through pricing changes and product improvements.

Recent actions such as the acquisition and integration of Melio along with expansion into US payments and rising use of AI features support the company’s long-term growth outlook.

(Source: Company Reports)